In a 2024 trial, 68% of Tirzepatide users reported reduced food noise within 8 weeks, with average weight loss hitting 15% (Semaglutide) and 21% (Tirzepatide)
Microdosing refers to the use of subtherapeutic or lower-than-standard doses of GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), with the aim of minimizing side effects while maintaining therapeutic benefits
One of its main roles is to promote the production of telomerase
Gray-market peptides near a regulatory inflection
Its during this life phase when insulin resistance may begin, affecting fat storage, body composition, blood sugar balance, inflammation, and cardiovascular health